Nektar Therapeutics: Q4 Earnings Insights

Nektar Therapeutics NKTR reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Nektar Therapeutics beat estimated earnings by 2.47%, reporting an EPS of $-0.79 versus an estimate of $-0.81.

Revenue was up $1.55 million from the same period last year.

Last quarter the company beat on EPS by $0.1 which was followed by a 19.22% drop in the share price the next day.

Here's a look at Nektar Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.8	-0.74	-0.72	-0.68
EPS Actual	-0.7	-0.69	-0.68	-0.65
Revenue Estimate	27.87M	25.98M	26.90M	30.01M
Revenue Actual	24.92M	28.33M	23.65M	23.46M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar